Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial DNA replication and repair machinery is a complex, multi-protein system responsible for the faithful duplication and maintenance of the bacterial genome [1, 3]. Central to this machinery is the replisome, which includes essential enzymes such as DNA polymerase III, helicases, primases, and sliding clamps (DnaN) that coordinate leading and lagging strand synthesis [4, 11]. Additionally, topoisomerases like DNA gyrase and topoisomerase IV manage the topological stress and decatenation required for successful replication and segregation [2, 8]. This machinery is a cornerstone of antimicrobial therapy, with the fluoroquinolone class of antibiotics being the most prominent inhibitors, acting by trapping DNA gyrase and topoisomerase IV in a state that causes lethal double-strand breaks [2, 10]. Other components, such as the sliding clamp and DNA ligase, are emerging as high-value targets for novel drug development to combat multi-drug resistant pathogens [1, 13]. Because bacterial replication proteins are structurally distinct from their eukaryotic counterparts, they offer a high degree of selectivity, although the rapid evolution of resistance remains a primary clinical challenge [5, 8].
Inhibition of DNA gyrase and topoisomerase IV by stabilizing enzyme-DNA cleaved complexes or inhibiting ATPase activity; inhibition of replicative DNA polymerases (e.g., Pol III); inhibition of DNA ligase; induction of DNA strand breaks; and targeting of the sliding clamp (DnaN) to disrupt processivity [2, 8, 10].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial DNA replication and repair machinery.